v3.26.1
Financial Instruments
6 Months Ended
Jun. 30, 2026
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
The fair value and amortized cost of cash equivalents and available-for-sale securities by major security type as of June 30, 2026 and as of December 31, 2025 are presented in the following tables:
June 30, 2026
Amortized CostUnrealized GainsUnrealized LossesFair Value
(In thousands)
Money market funds$34,201 $— $— $34,201 
Commercial paper142,709 (216)142,502 
Corporate bonds84,598 — (110)84,488 
U.S. treasury securities127,252 31 (178)127,105 
U.S. agency securities30,923 — (54)30,869 
Total cash equivalents and investments$419,683 $40 $(558)$419,165 
Classified as:
Cash equivalents$34,201 
Short-term investments293,978 
Long-term investments90,986 
Total cash equivalents and investments$419,165 
December 31, 2025
Amortized CostUnrealized GainsUnrealized LossesFair Value
(In thousands)
Money market funds$48,576 $— $— $48,576 
Commercial paper42,696 18 (10)42,704 
Corporate bonds53,636 69 — 53,705 
U.S. treasury securities75,990 167 — 76,157 
U.S. agency securities33,974 25 — 33,999 
Total cash equivalents and investments$254,872 $279 $(10)$255,141 
Classified as:
Cash equivalents$48,576 
Short-term investments198,522 
Long-term investments8,043 
Total cash equivalents and investments$255,141 
As of June 30, 2026, the amortized cost and fair value of cash equivalents and available-for-sale securities with remaining contractual maturities of less than 1 year were $328.5 million and $328.2 million, respectively, and the amortized cost and fair value of cash equivalents and for available-for-sale securities with remaining contractual maturities with maturities of 1 to 3 years were $91.2 million and $91.0 million, respectively.
There were no significant realized losses on available-for-sale securities for the three and six months ended June 30, 2026 and 2025. As of June 30, 2026, unrealized losses on available-for-sale securities are not attributed to credit risk. The Company believes that it is more likely than not that investments in an unrealized loss position will be held until maturity and all interest and principal will be received. The Company believes that an allowance for credit losses is unnecessary because the unrealized losses on certain of the Company’s available-for-sale securities are due to market factors. As of June 30, 2026 and December 31, 2025, there were no securities in a continuous net unrealized loss position for more than 12 months. To date, the Company has not recorded any impairment charges on available-for-sale securities.
The Company has made an accounting policy election not to recognize an allowance for credit losses for accrued interest receivable on available-for-sale securities. As of June 30, 2026 and December 31, 2025, the Company recognized $2.2 million and $1.5 million, respectively, of accrued interest receivable from available-for-sale securities within prepaid expenses and other current assets on the condensed balance sheets.